Redeye is adjusting its forecast following the recent news of Nectar Farms filing for liquidation. Heliospectra has now written off the order from Nectar Farms amounting to SEK 72m, which impacts Redeye's 2021-22 estimates significantly. The estimate revision also has bearing on the valuation and our Base case fair value is now around SEK 4.5 per share.